Laboratory of Tissue Engineering and Regenerative Medicine (TERM Lab)

@

Welcome

Welcome to the Laboratory of Tissue Engineering and Regenerative Medicine of National Yang-Ming University. We live in exciting times. To realize the vast potential of tissue engineering and other techniques aimed at repairing damaged or diseased tissues and organs, the National Yang-Ming University have established the Laboratory of Tissue Engineering and Regenerative Medicine (TERM Lab). The TERM Lab serves as one of the best operations for the University's leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, biosurgery and artificial and biohybrid organ devices. The TERM Lab is the most ambitious regenerative program in the nation, coupling biology and engineering. Success will save lives, bring economic recovery, empower recruitment of students, engineering faculty and surgeons, and build upon the pioneering achievements in organ transplantation.

We seek opportunities to involve other professionals in the dynamic and exciting programs of the TERM Lab. Participation and collaboration can take many forms from full-time employment by the National Yang-Ming University and Taipei City Hospital, to collaborative research projects, to participation in our seminars and colloquia that will be posted on this web site. If you want to contribute to the development of the TERM Lab, and to the growth of cellular and regenerative therapies, please contact the lead individuals for the focus areas listed on our web site, or direct your e-mail  inquires to me.

 

About Us

The promise of tissue engineering and regenerative medicine is truly astounding. Just as remarkable is that success in the laboratory, where all such endeavors must begin, will drive the clinical translation as well as the commercial activities that will lead to products. Regenerative medicine uses a variety of approaches to address tissue/organ insufficiency including:

  • The replacement of tissue function with entirely synthetic constructs (such as in artificial organs),
  • Functional restoration with constructs that comprise both synthetic and cellular components (such as in biohybrid organs),
  • The combination of temporary scaffolds with cellular components (such as in conventional tissue engineering), and
  • Cellular therapies, including those involving adult stem cells and genetically manipulated cells (such as for the repair of damaged tissue and muscle).

To realize the vast potential of tissue engineering and regenerative medicine aimed at repairing damaged or diseased tissues and organs, the TERM Lab of National Yang-Ming University serves as a single base of operations for the university's leading scientists and clinical faculty working to develop tissue engineering, cellular therapies, biosurgery and artificial and biohybrid organ devices.

The TERM Lab mission includes the development of innovative clinical protocols as well as the pursuit of rapid commercial transfer of its technologies related to regenerative medicine. Regenerative medicine is an emerging field that approaches the repair or replacement of tissues and organs by incorporating the use of cells, genes or other biological building blocks along with bioengineered materials and technologies.

The TERM Lab Director is Jason, Jui-Sheng SUN, MD., PhD. , who until accepting this assignment served as the Professor and Vice Chairman of the Department of Biomedical Engineering at the National Taiwan University Hospital. He also serves as the vice superintendent of the Taipei City Hospital. Through the Taipei City Hospitals expanded role and mission, other university faculty have joined forces to address promising opportunities in tissue engineering, adult-derived stem cell research and wound healing.

The TERM Lab's Mission Statement is:

To provide a national center of expertise in regenerative medicine focused on developing and delivering therapies that reestablish tissue and organ function impaired by disease, trauma or congenital abnormalities.

To foster the generation of scientific knowledge in regenerative medicine and to share that knowledge with researchers, clinicians and the public through educational activities, training and publications.

To educate and train scientists and engineers to pursue technologies related to regenerative medicine, and train a generation of clinicians in the implementation of regenerative therapies.

To support the commercialization of technologies in regenerative medicine and thereby accelerate the translation of research discoveries to clinical implementation and patient benefit.